Author Question: A female patient is taking filgrastim (Neupogen) to decrease the incidence of infection. The nurse ... (Read 56 times)

jon_i · **on:** Jul 23, 2018

A female patient is taking filgrastim (Neupogen) to decrease the incidence of infection. The nurse notices a small increase in the neutrophil count 2 days after starting therapy. The nurse's evaluation of the increase is that

A) the therapeutic effect of the drug is slow, and it is likely to cause adverse effects.
B) the drug therapy is proving to be ineffective.
C) the therapeutic effect of the drug is fully evident.
D) the increase in the neutrophil count is only transient.

Question 2

A 38-year-old man is being treated for HIV-1 with nevirapine (Viramune). Signs of severe liver dysfunction have been noted by the physician and a change in the drug therapy is necessary. The nurse explains to the patient that

A) the therapy will be discontinued.
B) the drug will be administered three times daily in divided doses.
C) the therapy should be reinitiated at half the previous dosage.
D) the dose should be escalated over a 2-week period.